Amplimune™ (100-dose)

Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is USDA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.

Amplimune™ (20-dose)

Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is USDA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.

Amplimune™ (5-dose)

Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is USDA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.

Equimune®

Equimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is approved by the USDA for the treatment of Equine Respiratory Disease Complex (ERDC) of viral origin.

Immunocidin® (canine)

Immunocidin, mycobacterium cell wall fraction (MCWF) immunostimulant, is USDA-approved for the intratumoral treatment of mixed mammary tumor and mammary adenocarcinoma in dogs.

Immunocidin® Equine

Immunocidin Equine, mycobacterium cell wall fraction (MCWF) immunostimulant, is USDA-approved for the intratumoral treatment of sarcoid tumors in horses.

Settle®

Settle, mycobacterium cell wall fraction (MCWF) immunostimulant, is approved by the USDA as an aid in the treatment of equine endometritis caused by Streptococcus zooepidemicus.